The anti-caries efficacy of a dentifrice containing 1.5% arginine and 1450 ppm fluoride as sodium monofluorophosphate assessed using Quantitative Light-induced Fluorescence (QLF)

被引:50
作者
Yin, W. [1 ]
Hu, D. Y. [1 ]
Li, X. [1 ]
Fan, X. [1 ]
Zhang, Y. P. [2 ]
Pretty, I. A. [3 ]
Mateo, L. R. [4 ]
Cummins, D. [2 ]
Ellwood, R. P. [3 ]
机构
[1] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Peoples R China
[2] Colgate Palmolive Technol Ctr, Piscataway, NJ USA
[3] Manchester Sci Pk, Colgate Palmolive Dent Hlth Unit, Manchester M15 6SH, Lancs, England
[4] LRM Stat Consulting, Hoboken, NJ USA
关键词
Arginine; Caries; Fluoride; Dentifrice; Arrest; Reversal; Enamel; Lesions; CARIES PREVENTION; DENTAL-CARIES;
D O I
10.1016/j.jdent.2010.04.004
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective: To compare the efficacy of a new dentifrice containing 1.5% arginine, an insoluble calcium compound and 1450 ppm fluoride to arrest and reverse naturally occurring buccal caries lesions in children relative to a positive control dentifrice containing 1450 ppm fluoride alone. Study design: Participants from Chengdu, Sichuan Province, China tested three dentifrices: a new dentifrice containing 1.5% arginine, an insoluble calcium compound, and 1450 ppm fluoride, as sodium monofluorophosphate, a positive control dentifrice containing 1450 ppm fluoride, as sodium fluoride, in a silica base, and a matched negative control dentifrice without arginine and fluoride. Quantitative Light-induced Fluorescence (QLF) was used to assess buccal caries lesions at baseline and after 3 and 6 months of product use. Results: 438 participants (initial age 9-13 years (mean 11.1 +/- 0.78) and 48.6% female) completed the study. No adverse events attributable to the products were reported during the course of the study. The subject mean Delta Q (mm(2) %), representing lesion volume, was 27.26 at baseline. After 6 months of product use, the Delta Q values for the arginine-containing, positive and negative control dentifrices were 13.46, 17.99 and 23.70 representing improvements from baseline of 50.6%, 34.0% and 13.1%. After 6 months product use, the differences between the pair wise comparisons for all three groups were statistically significant (p < 0.01). The arginine-containing dentifrice demonstrated an improvement after only 3 months that was almost identical to that achieved by the conventional 1450 ppm fluoride dentifrice after 6 months. Conclusion: The new dentifrice containing 1.5% arginine, an insoluble calcium compound, and 1450 ppm fluoride provides statistically significantly superior efficacy in arresting and reversing buccal caries lesions to a conventional dentifrice containing 1450 ppm fluoride alone. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S22 / S28
页数:7
相关论文
共 26 条
[1]  
Alfano MC, 2001, J AM DENT ASSOC, V132, P1153
[2]  
Angmar-Mansson B, 1987, Adv Dent Res, V1, P14
[3]  
Beltran-Aguilar Eugenio D., 2005, Morbidity and Mortality Weekly Report, V54, P1
[4]  
Cantore R, 2013, J Clin Dent, V24 Spec no A, pA32
[5]  
Cummins D, 2013, J Clin Dent, V24 Spec no A, pA1
[6]   The development and validation of a new technology, based upon 1.5% arginine, an insoluble calcium compound and fluoride, for everyday use in the prevention and treatment of dental caries [J].
Cummins, D. .
JOURNAL OF DENTISTRY, 2013, 41 :S1-S11
[7]  
Cummins D, 2006, COSMETIC SCI TECHNOL, V29, P323
[8]  
Featherstone JDB, 2006, PEDIATR DENT, V28, P128
[9]   The science and practice of caries prevention [J].
Featherstone, JDB .
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2000, 131 (07) :887-899
[10]  
Featherstone John D B, 2003, J Calif Dent Assoc, V31, P129